73 results returned.
Page   of  5

Walgreen Co. et al v. Allergan, Inc
District Court: Eastern District of New York    Status: Pending
Four drug retailers, including Walgreens and Albertsons, filed an antitrust suit alleging that Allergan devised and carried out a multifaceted and anticompetitive scheme to maintain …
Association for Accessible Medicines v. Frosh
District Court: District of Maryland    Status: Decided
In a significant victory for the pharmaceutical industry, the 4th U.S. Circuit Court of Appeals found Maryland’s landmark 2017 law (HB 631), which punishes generic …
PhRMA v. David
District Court: Eastern District of California    Status: Pending
PhRMA is challenging California’s drug price transparency law SB 17 alleging that the law is unconstitutional because it violates the Commerce Clause, the First Amendment, …
Pharmaceutical Care Management Association (PCMA) v. Rutledge
District Court: Eastern District of Arkansas    Status: Pending
Act 900 (SB 688), enacted in 2015, required disclosure of generic drug pricing and sets a floor on prices that PBMs can pay to pharmacies …
PhRMA and BIO v. Sandoval
District Court: District of Nevada    Status: Decided
In September 2017, just three months after Nevada passed its insulin transparency law (SB 539) in June 2017 to increase transparency over the price of …
In re Express Scripts/Anthem ERISA Litigation
District Court: Southern District of New York    Status: Pending
The district court dismissed a proposed class action against Anthem Inc. and Express Scripts Inc. over drug pricing methods, holding that the companies can’t be …
Alcon Labs., Inc. v. Cottrell
District Court: District of New Jersey    Status: Decided
Consumers brought putative class action against manufacturers and distributors of prescription eye medication, alleging they packaged medication in such a way as to force consumers …
Drogueria Betances LLC v. Novartis Pharmaceuticals Corp.
District Court: Southern District of New York    Status: Pending
Novartis Pharmaceuticals Corp. allegedly agreed with Par Pharmaceuticals Inc. to squelch generic competition to Novartis’s hypertension drug Exforge, resulting in buyers paying millions more than …
Federal Trade Commission v. AbbVie Inc. et al.
District Court: Eastern District of Pennsylvania    Status: Decided
FTC alleged AbbVie sued generic companies for patent infringement over their proposed generic version of the testosterone gel, AndroGel, without justifiable grounds but merely to …
In the Matter of Impax Laboratories Inc.
District Court: Federal Trade Commission    Status: Pending
The Federal Trade Commission sued generic drugmaker Impax Laboratories Inc. for allegedly accepting more than $100 million to delay its release of a generic version …
In Re: Generic Pharmaceuticals Pricing Antitrust Litigation
District Court: Eastern District of Pennsylvania    Status: Pending
Plaintiffs are attorney generals from 48 states, Puerto Rico, and the District of Columbia, as well as classes of private plaintiffs that filed an antitrust …
In re: EPIPEN (Epinephrine Injection, USP) Marketing, Sales Practices, and Antitrust Litigtion
District Court: District of Kansas    Status: Pending
The plaintiffs in the case allege Mylan N.V. created and exploited an EpiPen monopoly by providing aggressive rebates and incentives to pharmacy benefit managers to …
Sentry Data Sys. v. CVS Health
District Court: S.D. Florida    Status: Pending
340B administrator Sentry Data Systems sued CVS pharmacy alleging that since CVS aquired Wellpartner, the company has engaged in unlawful tying, using its status as …
RxStrategies v. CVS Pharmacy
District Court: M.D. Florida    Status: Pending
340B administrator RxStrategies sued CVS pharmacy alleging that since CVS aquired Wellpartner, the company has engaged in unlawful tying, using its status as a “must …
UnitedHealth Group anti-competitive behavior in elder care market
District Court:    Status: Decided
In January 2016, the New York Attorney General announced a settlement with UnitedHealth Group to protect competition in the elder care market. The settlement follows a $100,000 …
In re: Suboxone Antitrust Litigation (State of Wisconsin, et al. v. Indivior Inc, et al.)
District Court: E.D. Pennsylvania    Status: Pending
In September 2016, 35 state attorneys general and the District of Columbia brought a multi-district case against pharmaceutical manufacturer Indivior, MonoSol RX et al.,  alleging …
73 results returned.
Page   of  5